Pro-Chondrogenic Effect of miR-221 and Slug Depletion in Human MSCs

Stem Cell Reviews and Reports

Volumn 10, Issue 6, 2014, Pages 841-855

  Lolli, Andrea ^a   Lambertini, Elisabetta ^a   Penolazzi, Letizia ^a   Angelozzi, Marco ^a   Morganti, Claudia ^a   Franceschetti, Tiziana ^a,b   Pelucchi, Stefano ^a   Gambari, Roberto ^a   Piva, Roberta ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Chondrogenic potential; Gene silencing; Human mesenchymal stem cells; miR 221; Slug

Indexed keywords

MICRORNA; MIRN221 MICRORNA, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

CARTILAGE CELL; CHONDROGENESIS; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

CHONDROCYTES; CHONDROGENESIS; HUMANS; MESENCHYMAL STROMAL CELLS; MICRORNAS; TRANSCRIPTION FACTORS;

EID: 84930824325     PISSN: 26293269     EISSN: 26293277     Source Type: Journal    
DOI: 10.1007/s12015-014-9532-1     Document Type: Review

References (51)

1. Caplan, A. I. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Journal of Cellular Physiology, 213, 341–347.
2. Arthur, A., Zannettino, A., & Gronthos, S. (2009). The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. Journal of Cellular Physiology, 218, 237–245.
3. Vinatier, C., Mrugala, D., Jorgensen, C., Guicheux, J., & Noël, D. (2009). Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends in Biotechnology, 27, 307–314.
4. Barzilay, R., Melamed, E., & Offen, D. (2009). Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem Cells, 27, 2509–2515.
5. Palmer, G. D., Steinert, A., Pascher, A., Gouze, E., Gouze, J. N., Betz, O., et al. (2005). Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Molecular Therapy, 12, 219–228.
6. Oldershaw, R. A. (2012). Cell sources for the regeneration of articular cartilage: the past, the horizon and the future. International Journal of Experimental Pathology, 93, 389–400.
7. de Crombrugghe, B., Lefebvre, V., & Nakashima, K. (2001). Regulatory mechanisms in the pathways of cartilage and bone formation. Current Opinion in Cell Biology, 13, 721–727.
8. Steinert, A. F., Ghivizzani, S. C., Rethwilm, A., Tuan, R. S., Evans, C. H., et al. (2007). Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Research & Therapy, 9, 213.
9. Roobrouck, V. D., Vanuytsel, K., & Verfaillie, C. M. (2011). Concise review: culture mediated changes in fate and/or potency of stem cells. Stem Cells, 29, 583–589.
10. Caplen, N. J. (2004). Gene Therapy Progress and Prospects. Downregulating gene expression: the impact of RNA interference. Gene Therapy, 11, 1241–1248.
11. Cheema, S. K., Chen, E., Shea, L. D., & Mathur, A. B. (2007). Regulation and guidance of cell behavior for tissue regeneration via the siRNA mechanism. Wound Repair and Regeneration, 15, 286–295.
12. Cobaleda, C., Pérez-Caro, M., Vicente-Dueñas, C., & Sánchez-García, I. (2007). Function of the zinc-finger transcription factor SNAI2 in cancer and development. Annual Reviewes Genetics, 41, 41–61.
13. Garofalo, M., Quintavalle, C., Romano, G., Croce, C. M., & Condorelli, G. (2012). miR221/222 in cancer: their role in tumor progression and response to therapy. Current Molecular Medicine, 12, 27–33.
14. Seki, K., Fujimori, T., Savagner, P., Hata, A., Aikawa, T., Ogata, N., et al. (2003). Mouse Snail family transcription repressors regulate chondrocyte, extracellular matrix, type II collagen, and aggrecan. Journal of Biological Chemistry, 278, 41862–41870.
15. Goldring, M. B., Tsuchimochi, K., & Ijiri, K. (2006). The control of chondrogenesis. Journal of Cellular Biochemistry, 97, 33–44.
16. Kim, D., Song, J., & Jin, E. J. (2010). MicroRNA-221 regulates chondrogenic differentiation through promoting proteosomal degradation of slug by targeting Mdm2. Journal of Biological Chemistry, 285, 26900–26907.
17. Bakhshandeh, B., Soleimani, M., Paylakhi, S. H., & Ghaemi, N. (2012). A microRNA signature associated with chondrogenic lineage commitment. Journal of Genetics, 91, 171–182.
18. Karlsen, T. A., Shahdadfar, A., & Brinchmann, J. E. (2011). Human primary articular chondrocytes, chondroblasts-like cells, and dedifferentiated chondrocytes: differences in gene, microRNA, and protein expression and phenotype. Tissue Engineering. Part C, Methods, 17, 219–227.
19. Hemavathy, K., Guru, S. C., Harris, J., Chen, J. D., & Ip, Y. T. (2000). Human slug is a repressor that localizes to sites of active transcription. Molecular and Cellular Biology, 20, 5087–5095.
20. Gordeladze, J. O., Djouad, F., Brondello, J. M., Noël, D., Duroux-Richard, I., Apparailly, F., et al. (2009). Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs. Acta Pharmacologica Sinica, 30, 1369–1384.
21. Yang, B., Guo, H., Zhang, Y., Chen, L., Ying, D., & Dong, S. (2011). MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PloS One, 6, e21679.
22. Hong, E., & Reddi, A. H. (2012). MicroRNAs in chondrogenesis, articular cartilage, and osteoarthritis: implications for tissue engineering. Tissue Engineering Part B, 18, 445–453.
23. Penolazzi, L., Tavanti, E., Vecchiatini, R., Lambertini, E., Vesce, F., Gambari, R., et al. (2010). Encapsulation of mesenchymal stem cells from Wharton’s jelly in alginate microbeads. Tissue Engineering. Part C, Methods, 16, 141–155.
24. Wachsmuth, L., Soder, S., Fan, Z., Finger, F., & Aigner, T. (2006). Immunolocalization of matrix proteins in different human cartilage subtypes. Histology and Histopathology, 21, 477–485.
25. Candrian, C., Vonwil, D., Barbero, A., Bonacina, E., Miot, S., Farhadi, J., et al. (2008). Engineered cartilage generated by nasal chondrocytes is responsive to physical forces resembling joint loading. Arthritis and Rheumatism, 58, 197–208.
26. Pleumeekers, M. M., Nimeskern, L., Koevoet, W. L., Kops, N., Poublon, R. M., Stok, K. S., et al. (2014). The in vitro and in vivo capacity of culture-expanded human cells from several sources encapsulated in alginate to form cartilage. European Cells and Materials, 27, 264–280.
27. Do Amaral, R. J. F. C., Da Pedrosa, C. S. G., Kochem, M. C. L., Da Silva, K. R., Aniceto, M., Claudio-da-Silva, C., et al. (2012). Isolation of human nasoseptal chondrogenic cells: a promise for cartilage engineering. Stem Cell Research, 8, 292–299.
28. Lambertini, E., Lisignoli, G., Torreggiani, E., Manferdini, C., Gabusi, E., Franceschetti, T., et al. (2009). Slug gene expression supports human osteoblast maturation. Cellular and Molecular Life Sciences, 66, 3641–3653.
29. Lambertini, E., Lolli, A., Vezzali, F., Penolazzi, L., Gambari, R., & Piva, R. (2012). Correlation between slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells. BMC Cancer, 12, 445.
30. Medici, D., Hay, E. D., & Olsen, B. R. (2008). Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Molecular Biology of the Cell, 19, 4875–4887.
31. Brandl, M., Seidler, B., Haller, F., Adamski, J., Schmid, R. M., Saur, D., et al. (2010). IKK(α) controls canonical TGF(ß)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells. Journal of Cell Science, 123, 4231–4239.
32. Malik, T. H., Shoichet, S. A., Latham, P., Kroll, T. G., Peters, L. L., & Shivdasani, R. A. (2001). Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1. EMBO Journal, 20, 1715–1725.
33. Umlauf, D., Frank, S., Pap, T., & Bertrand, J. (2010). Cartilage biology, pathology, and repair. Cellular and Molecular Life Sciences, 67, 4197–4211.
34. Lefebvre, V., & Smits, P. (2005). Transcriptional control of chondrocyte fate and differentiation. Birth Defects Research Part C, 75, 200–212.
35. Sun, W., Julie Li, Y. S., Huang, H. D., Shyy, J. Y., & Chien, S. (2010). microRNA: a master regulator of cellular processes for bioengineering systems. Annual Reviews Biomedical Engineering, 12, 1–27.
36. Anokye-Danso, F., Snitow, M., & Morrisey, E. E. (2012). How microRNAs facilitate reprogramming to pluripotency. Journal of Cell Science, 125, 4179–4187.
37. Torreggiani, E., Lisignoli, G., Manferdini, C., Lambertini, E., Penolazzi, L., Vecchiatini, R., et al. (2012). Role of Slug transcription factor in human mesenchymal stem cells. Journal of Cellular and Molecular Medicine, 16, 740–751.
38. Handorf, A. M., & Li, W. J. (2011). Fibroblast growth factor-2 primes human mesenchymal stem cells for enhanced chondrogenesis. PloS One, 6, e22887.
39. Temenoff, J. S., & Mikos, A. G. (2000). Review: tissue engineering for regeneration of articular cartilage. Biomaterials, 21, 431–440.
40. Gadjanski, I., Spiller, K., & Vunjak-Novakovic, G. (2012). Time-dependent processes in stem cell-based tissue engineering of articular cartilage. Stem Cell Reviews and Reports, 8, 863–881.
41. Johnstone, B., Alini, M., Cucchiarini, M., Dodge, G. R., Eglin, D., Guilak, F., et al. (2013). Tissue engineering for articular cartilage repair - the state of the art. European Cells & Materials, 25, 248–267.
42. van Beuningen, H. M., Glansbeek, H. L., van der Kraan, P. M., & van den Berg, W. B. (2000). Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-b injections. Osteoarthritis and Cartilage, 8, 25–33.
43. Narcisi, R., Signorile, L., Verhaar, J. A., Giannoni, P., & van Osch, G. J. (2012). TGFβ inhibition during expansion phase increases the chondrogenic re-differentiation capacity of human articular chondrocytes. Osteoarthritis and Cartilage, 20, 1152–1160.
44. de Vries-van Melle, M. L., Narcisi, R., Kops, N., Koevoet, W. J., Bos, P. K., Murphy, J. M., et al. (2014). Chondrogenesis of mesenchymal stem cells in an osteochondral environment is mediated by the subchondral bone. Tissue Engineering. Part A, 20, 23–33.
45. Zhen, G., Wen, C., Jia, X., Li, Y., Crane, J. L., Mears, S. C., et al. (2013). Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nature Medicine, 19, 704–712.
46. Wuelling, M., Kaiser, F. J., Buelens, L. A., Braunholz, D., Shivdasani, R. A., Depping, R., et al. (2009). Trps1, a regulator of chondrocyte proliferation and differentiation, interacts with the activator form of Gli3. Developmental Biology, 328, 40–53.
47. Tortelli, F., & Cancedda, R. (2009). Three-dimensional cultures of osteogenic and chondrogenic cells: a tissue engineering approach to mimic bone and cartilage in vitro. European Cells & Materials, 17, 1–14.
48. Caron, M. M., Emans, P. J., Coolsen, M. M., Voss, L., Surtel, D. A., Cremers, A., et al. (2012). Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures. Osteoarthritis and Cartilage, 20, 1170–1178.
49. Lisignoli, G., Manferdini, C., Lambertini, E., Zini, N., Angelozzi, M., Gabusi, E., et al. Chondrogenic Potential of Slug-depleted hMSCs. Tissue Eng Part A, in press. doi:10.1089/ten.TEA.2013.0343.
50. Mahmoudifa, N., & Doran, P. M. (2012). Chondrogenesis and cartilage tissue engineering: the longer road to technology development. Trends in Biotechnology, 30, 166–176.
51. Di Leva, G., Gasparini, P., Piovan, C., Ngankeu, A., Garofalo, M., Taccioli, C., et al. (2010). MicroRNA cluster 221–222 and estrogen receptor alpha interactions in breast cancer. Journal of the National Cancer Institute, 102, 706–721.